Integra Medical Center, a long-term partner of PlacidWay, a medical provider and information resource on medical technologies, accredited healthcare facilities and surgeons around the world, announces its intention to begin placenta-based stem cell clinical trials for Parkinson's disease in March 2011.
Dr. Omar Gonzalez of Integra Medical Center, located in Nuevo Progresso and Tamps, Mexico, announces an upcoming placenta stem cell clinical trial for individuals diagnosed with Parkinson's disease. Dr. Gonzalez and Integra Medical center seek patients diagnosed with idiopathic Parkinson's disease who have not received deep brain stimulator therapy or previous stem cell therapies for five years. Individuals will be required to send clinical data on a monthly basis and should be able to travel. Dr. Gonzalez and his medical center are offering the limited time special package for $6,000.
Dr. Gonzalez of Integra Medical Center says, "Since the early 1990s, I have utilized placental stem cell therapies to treat thousands of patients and perfected stem cell therapies and placental stem cell technologies through my own research and research methodologies from around the world. Clinical trials and treatments for Parkinson's patients may help reduce tremors, restore fine motor movement, improve stability and gait, cognitive function and slow the disease process."
Placenta stem cell therapy (also known as PST) has been researched for over two decades, but only recently have researchers and scientists understood the impact that placenta stem cell therapy and treatment has on a multitude of autoimmune and chronic illness conditions and symptoms. Placental stem cells in no way harm mothers or their infants, and are collected from the placental following the birth process, where typically placenta or afterbirth has been discarded.
"Dr. Gonzalez and his office offer healthier futures to individuals around the world seeking the benefits of stem cell treatments not yet available in the United States," says Pramod Goel, CEO of PlacidWay. "Long delays, despite a growing number of clinical trials in the United States, have encouraged thousands of Americans to travel beyond our borders to receive their last hopes for health and wellness in other countries. Dr. Gonzalez and his team at Integra Medical Center are among the best when it comes to placenta stem cell research and therapies abroad."
Individuals not only from North America, but also around the world are invited to take part in the placenta stem cell clinical trials offered by Integra Medical Center. Clinical trials engage in research studies following predetermined protocols to study the efficacy of the new treatments and therapies. Outcomes are measured among participants, some of which undergo actual cell therapies while others receive placebos in order to compare and measure outcomes.
Dr. Gonzalez encourages individuals diagnosed with Parkinson's disease to take active roles in their own health care and wellness and keep abreast of new technologies and research that may offer hope for relief of symptoms associated with Parkinson's disease. Participation in clinical trials enables individuals to receive new treatments before they become available on the general market and receive the expertise of specialists and healthcare facilities not offered elsewhere.
For additional information regarding Dr. Omar Gonzalez, the Integra Medical Center or PlacidWay for information regarding placental stem cell research, therapies and education, visit www.placidway.com or www.integramedicalcenter.com.
About the Company:
PlacidWay is a leader in the medical tourism industry, dedicated to offering accurate, up-to-date information and resources regarding medical travel, international providers, treatments, procedures and destinations for international travelers. For press inquiries about PlacidWay or to arrange an interview with Pramod Goel, call +1.303.578.0719, or visit in[email protected]
Please Click here to request more information from Dr. Omar Gonzalez.